Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilization

In Canada, intravenous immune globulin (IVIg) products are licensed for six disease indications, however it has been demonstrated that patients with a number of other conditions also benefit from IVIg. Here we report the routine clinical use of Octagam(®) 10 % across three Canadian institutions. A t...

Descripción completa

Detalles Bibliográficos
Autores principales: Betschel, Stephen D., Warrington, Richard J., Schellenberg, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962395/
https://www.ncbi.nlm.nih.gov/pubmed/27468299
http://dx.doi.org/10.1186/s13223-016-0138-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962395/
https://www.ncbi.nlm.nih.gov/pubmed/27468299
http://dx.doi.org/10.1186/s13223-016-0138-9

Ejemplares similares